BC

Broadwood Capital Portfolio holdings

AUM $1.53B
1-Year Est. Return 36.91%
This Quarter Est. Return
1 Year Est. Return
+36.91%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.23B
AUM Growth
-$45.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
8
New
Increased
Reduced
Closed

Top Buys

1
+$28.3M
2
+$15.8M
3
+$10.8M
4
LCTX icon
Lineage Cell Therapeutics
LCTX
+$3.57M

Top Sells

1
+$13.9M
2
+$8.98M

Sector Composition

1 Consumer Staples 39.33%
2 Industrials 29.66%
3 Healthcare 22.47%
4 Technology 0.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$65.3B
$485M 39.33%
8,295,690
AXON icon
2
Axon Enterprise
AXON
$57.5B
$366M 29.66%
696,075
-26,346
STAA icon
3
STAAR Surgical
STAA
$1.28B
$220M 17.79%
12,455,264
+1,606,633
IWM icon
4
iShares Russell 2000 ETF
IWM
$70.7B
$94.7M 7.67%
474,920
-45,000
IMDX
5
Insight Molecular Diagnostics
IMDX
$172M
$34.9M 2.83%
11,410,100
+5,165,695
LCTX icon
6
Lineage Cell Therapeutics
LCTX
$438M
$22.4M 1.81%
49,560,992
+7,894,737
OLO
7
DELISTED
Olo Inc
OLO
$10.8M 0.87%
+1,782,334
SER icon
8
Serina Therapeutics
SER
$52.7M
$483K 0.04%
85,219